Regulatory and compliance
The challenge of meeting regulatory compliance obligations, is something that every business is facing. Mandatory legal requirements are increasing as is the pressure from stakeholders to be a good corporate citizen. This requires an up-to-date grip on new developments; for example, the growing area of environmental, social and governance (ESG) measures that now form an important part of every business's compliance framework and play an inherent role in corporate strategy.
Osborne Clarke's Global Compliance team works across a broad range of regulatory disciplines and with a wide range of regulators. We can advise on current and developing risks that regulation creates, manage these in a commercial way and liaise with regulators.
Article list
Advertising and marketing regulation
Welcome to the latest edition of Marketinglaw
19/12/2025
Read time
1m
Financial Services
Six a day? FCA sets out reconciliation rules to address safeguarding risks for UK payment and e-money firms
Steps include both internal and external safeguarding tests and a second 'day after receipt' check
17/12/2025
Read time
5m
Real estate
How can England and Wales solve its fly-tipping crisis?
Why legal reform is needed for faster court possession orders against trespassers
16/12/2025
Read time
5m
Life Sciences and Healthcare
European Parliament and Council provisional deal on new genomic techniques brings relaxation of gene editing a step closer
Two-tier categorisation of NGT plants endorsed alongside a patent ban rowback but patent transparency measures agreed
16/12/2025
Read time
5m
Life Sciences and Healthcare
EU's new bioeconomy strategy intends to harness sustainable innovation in life sciences and healthcare
Strategy aims to take advantage of 'biotechnology revolution', boost innovation and deliver sustainable solutions – what does this mean for...
15/12/2025
Read time
6m
IT and data
UK Cyber Security and Resilience Bill: pragmatic overhaul or regulatory overload?
The key changes and action points for businesses, and how the bill compares with the EU NIS2
11/12/2025
Read time
7m
The Digital Markets Competition and Consumers Act (DMCCA)
UK CMA finalises guidance on price transparency under DMCCA and begins enforcement action
From holidays to fashion, fourteen sectors under scrutiny as the regulator finalises guidance on total price requirements
10/12/2025
Read time
6m
Life Sciences and Healthcare
The US BIOSECURE Act: is your supply chain at risk?
The legislation could be enacted by the end of the year, with potentially wide-ranging consequences for biotech companies undertaking federal...
10/12/2025
Read time
6m
GDPR for HR
GDPR for HR | December 2025
Data subject access requests: the impact of AI, the Data (Use and Access) Act, and ICO enforcement
10/12/2025
Read time
6m
Life Sciences and Healthcare
EU triggers mandatory Eudamed use for diagnostics and medtech from May 2026
First modules declared functional under phased approach, with vigilance and clinical studies still to follow
09/12/2025
Read time
5m
Financial regulation
The EU's SFDR 2.0 – what do asset managers need to know?
The European Commission has published its proposals for a significant overhaul of the EU’s sustainable finance disclosure framework
09/12/2025
Read time
8m
Business crime
UK Serious Fraud Office publishes guidance on how it will evaluate corporate compliance programmes
SFO sets expectations on compliance, cooperation and failure to prevent fraud
08/12/2025
Read time
3m
Competition, antitrust and trade
New EU economic‑security roadmap resets the bar for foreign investment into Europe
European Commission tightens foreign investment scrutiny, with plans to monitor portfolio investments for the first time
08/12/2025
Read time
4m
Life Sciences and Healthcare
Medical devices, diagnostics and pharma win concessions in EU Digital Omnibus proposal
Commission acknowledges implementation challenges, adjusts high-risk AI requirements for the life sciences sector
08/12/2025
Read time
6m
Life Sciences and Healthcare
Autumn Budget 2025: what does recent government policy mean for UK life sciences and healthcare?
Targeted R&D support and faster regulatory pathways will be boosted by landmark UK-US pharmaceuticals deal
02/12/2025
Read time
7m
Advertising and marketing regulation
Marketinglaw: December 2025
Welcome to the latest edition of Marketinglaw
19/12/2025
Read time
1m
Financial Services
Six a day? FCA sets out reconciliation rules to address safeguarding risks for UK payment and e-money firms
Steps include both internal and external safeguarding tests and a second 'day after receipt' check
17/12/2025
Read time
5m
Real estate
How can England and Wales solve its fly-tipping crisis?
Why legal reform is needed for faster court possession orders against trespassers
16/12/2025
Read time
5m
Life Sciences and Healthcare
European Parliament and Council provisional deal on new genomic techniques brings relaxation of gene editing a step closer
Two-tier categorisation of NGT plants endorsed alongside a patent ban rowback but patent transparency measures agreed
16/12/2025
Read time
5m
Life Sciences and Healthcare
EU's new bioeconomy strategy intends to harness sustainable innovation in life sciences and healthcare
Strategy aims to take advantage of 'biotechnology revolution', boost innovation and deliver sustainable solutions – what does this mean for...
15/12/2025
Read time
6m
IT and data
UK Cyber Security and Resilience Bill: pragmatic overhaul or regulatory overload?
The key changes and action points for businesses, and how the bill compares with the EU NIS2
11/12/2025
Read time
7m
The Digital Markets Competition and Consumers Act (DMCCA)
UK CMA finalises guidance on price transparency under DMCCA and begins enforcement action
From holidays to fashion, fourteen sectors under scrutiny as the regulator finalises guidance on total price requirements
10/12/2025
Read time
6m
Life Sciences and Healthcare
The US BIOSECURE Act: is your supply chain at risk?
The legislation could be enacted by the end of the year, with potentially wide-ranging consequences for biotech companies undertaking federal...
10/12/2025
Read time
6m
GDPR for HR
GDPR for HR | December 2025
Data subject access requests: the impact of AI, the Data (Use and Access) Act, and ICO enforcement
10/12/2025
Read time
6m
Life Sciences and Healthcare
EU triggers mandatory Eudamed use for diagnostics and medtech from May 2026
First modules declared functional under phased approach, with vigilance and clinical studies still to follow
09/12/2025
Read time
5m
Financial regulation
The EU's SFDR 2.0 – what do asset managers need to know?
The European Commission has published its proposals for a significant overhaul of the EU’s sustainable finance disclosure framework
09/12/2025
Read time
8m
Business crime
UK Serious Fraud Office publishes guidance on how it will evaluate corporate compliance programmes
SFO sets expectations on compliance, cooperation and failure to prevent fraud
08/12/2025
Read time
3m
Competition, antitrust and trade
New EU economic‑security roadmap resets the bar for foreign investment into Europe
European Commission tightens foreign investment scrutiny, with plans to monitor portfolio investments for the first time
08/12/2025
Read time
4m
Life Sciences and Healthcare
Medical devices, diagnostics and pharma win concessions in EU Digital Omnibus proposal
Commission acknowledges implementation challenges, adjusts high-risk AI requirements for the life sciences sector
08/12/2025
Read time
6m
Life Sciences and Healthcare
Autumn Budget 2025: what does recent government policy mean for UK life sciences and healthcare?
Targeted R&D support and faster regulatory pathways will be boosted by landmark UK-US pharmaceuticals deal
02/12/2025
Read time
7m